Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Create Stock SIPAutomate your investments in this
Performance
Open
5.92Prev. Close
5.92Volume
2,891Total traded value
0.00 CrUpper Circuit
6.21Lower Circuit
5.63Fundamentals
| Market Cap | ₹6.07Cr |
| ROE | 2.56% |
| P/E Ratio(TTM) | 296.00 |
| EPS(TTM) | 0.02 |
| P/B Ratio | 7.05 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.79 |
| Book Value | 0.84 |
| Debt to Equity | 3.04 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Hindustan Bio
Hindustan Bio Sciences is engaged in manufacturing and selling pharmaceutical products, primarily focusing on exporting finished formulations of eye and ear drops. The company's philosophy is backed by principles of Concern, Commitment, Ethics, Excellence, and Learning in all its relationships with its stakeholders. It recorded a net profit of ₹5.76 Lakhs in FY 2023-24, a significant turnaround from a net loss in the previous year.;
| Parent Organisation | Hindustan Bio Sciences Limited |
| BSE Symbol | 532041 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.18 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.75 | ||
| Wockhardt | NA (0.00%) | -421.02 | ||
| Cohance Lifesciences | NA (0.00%) | 65.35 |
2025
31
Oct
Quarterly Result
Release date
31
Jul
Quarterly Result
Release date
30
May
Annual Result
Release date
30
Jan
Quarterly Result
Release date
2024
30
Oct
Quarterly Result
Release date
31
Jul
Quarterly Result
Release date
25
May
Result
Release date
Events calendar
View upcoming events in other stocks